100 Participants Needed

Cognitive Behavioral Therapy for Breast Cancer

AC
Overseen ByAlejandra Cuartas-Abril, M.S.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
Must be taking: Aromatase inhibitors
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It focuses on improving adherence to Aromatase Inhibitor medications, so you may need to continue those if you are already taking them.

What data supports the effectiveness of the treatment Cognitive Behavioral Therapy based Pain Management Program for breast cancer?

Research shows that cognitive-behavioral interventions, which include teaching patients strategies to manage pain, are effective in reducing pain and suffering in cancer patients. These interventions help improve patients' ability to manage their pain and may reduce the need for pain medication.12345

Is Cognitive Behavioral Therapy safe for breast cancer patients?

Cognitive Behavioral Therapy (CBT) has been used safely in breast cancer patients to help manage distress and pain, with studies showing improvements in anxiety and depression without significant safety concerns.12567

How does Cognitive Behavioral Therapy for Breast Cancer differ from other treatments?

Cognitive Behavioral Therapy (CBT) for breast cancer is unique because it focuses on managing pain through psychological techniques like education, relaxation, and goal setting, rather than relying solely on medications. This approach helps improve mental well-being and coping strategies, which can enhance overall quality of life for patients.178910

What is the purpose of this trial?

The purpose of this research is to evaluate the effectiveness of a multidisciplinary pain management program for AIMSS in reducing pain, subjective cognitive complaints, psychological distress, and impaired functional status resulting in improved adherence to Aromatase Inhibitor medications compared to usual care. We want to identify predictors of improvement in pain, functional status, subjective cognition and mood following participation in the program.

Research Team

BB

Barbara Bruce, Ph.D., LP

Principal Investigator

Mayo Clinic

Eligibility Criteria

This trial is for breast cancer survivors over 18 years old with Stage 0-III hormone receptor-positive (HR+) breast cancer, who have an ECOG performance status of ≤2 and are seeking ways to manage pain and improve quality of life. It's not open to those with Stage IV HR+ breast cancer or under the age of 18.

Inclusion Criteria

I can take care of myself and am up and about more than half of the day.
I have early to locally advanced hormone-receptor positive breast cancer and need symptom management.

Exclusion Criteria

My breast cancer is stage 4 and hormone receptor positive.
I am under 18 years old.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants in the treatment group will participate in a multicomponent pain management program in addition to standard of care treatment

6 months
Regular visits as per study protocol

Follow-up

Participants are monitored for adherence to Aromatase Inhibitors and other outcomes such as pain, cognitive function, and psychological distress

6 months
Follow-up assessments at 3 and 6 months

Treatment Details

Interventions

  • Cognitive Behavioral Therapy based Pain Management Program
Trial Overview The study tests a multidisciplinary Cognitive Behavioral Therapy (CBT) based Pain Management Program aimed at reducing pain, cognitive issues, distress, and functional problems in order to help patients better adhere to Aromatase Inhibitor medications.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment GroupExperimental Treatment1 Intervention
Subjects randomized to the treatment group will participate in a multicomponent pain treatment program in addition to standard of care treatment.
Group II: Control GroupActive Control1 Intervention
Subjects randomized to the control group will continue to receive standard of care treatment. At the end of the study, the control group participants will be offered the multicomponent pain treatment program.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+

Findings from Research

Cognitive-behavioral interventions have been shown to effectively control symptoms and reduce suffering in patients experiencing cancer pain, highlighting their importance as a nonmedical treatment option.
The article provides theoretical and technical principles of these interventions, supported by two case reports that demonstrate their practical application in real-world scenarios.
Cognitive-behavioral interventions in management of cancer pain: principles and applications.Fishman, B., Loscalzo, M.[2019]
A new model has been proposed to help predict which cognitive-behavioral interventions will be effective for managing cancer pain, based on factors like a patient's skills, coping style, and past experiences with pain management.
The model aims to provide nurses with a theoretical framework to choose the most suitable intervention for each patient, but further testing is needed to validate its effectiveness and accuracy.
A model for cognitive-behavioral interventions in cancer pain management.Kwekkeboom, KL.[2019]
The management of pain in oncology patients involves a combination of cognitive-behavioral, psychosocial, and pharmacologic strategies, each offering unique benefits for patient care.
These approaches not only help alleviate pain but also enhance patients' understanding of their condition and improve their coping mechanisms for dealing with cancer-related pain.
Therapeutic strategies for cancer pain management.Miller, TW., Spiro, K., Jay, LL.[2018]

References

Cognitive-behavioral interventions in management of cancer pain: principles and applications. [2019]
A model for cognitive-behavioral interventions in cancer pain management. [2019]
Therapeutic strategies for cancer pain management. [2018]
Effect of Pain Coping Skills Training on Pain and Pain Medication Use for Women With Breast Cancer. [2023]
Predictors of Response to an Evidence-Based Behavioral Cancer Pain Management Intervention: An Exploratory Analysis From a Clinical Trial. [2021]
Cognitive behavioral therapy techniques for distress and pain in breast cancer patients: a meta-analysis. [2018]
A pain management program for chronic cancer-treatment-related pain: a preliminary study. [2022]
Pain Management in Breast Cancer Patients: A Multidisciplinary Approach. [2021]
The management of chronic pain in patients with breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Society of Palliative Care Physicians. Canadian Association of Radiation Oncologists. [2018]
10.United Statespubmed.ncbi.nlm.nih.gov
The Efficacy of Cognitive-Behavioral Group Therapy on Depression, Anxiety, and Pain-Coping Strategies in Women With Breast Cancer. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security